Cargando…
Global health equity in United Kingdom university research: a landscape of current policies and practices
BACKGROUND: Universities are significant contributors to research and technologies in health; however, the health needs of the world’s poor are historically neglected in research. Medical discoveries are frequently licensed exclusively to one producer, allowing a monopoly and inequitable pricing. Si...
Autores principales: | Gotham, Dzintars, Meldrum, Jonathan, Nageshwaran, Vaitehi, Counts, Christopher, Kumari, Nina, Martin, Manuel, Beattie, Ben, Post, Nathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5057402/ https://www.ncbi.nlm.nih.gov/pubmed/27724907 http://dx.doi.org/10.1186/s12961-016-0148-6 |
Ejemplares similares
-
Research Investments in Global Health: A Systematic Analysis of UK Infectious Disease Research Funding and Global Health Metrics, 1997–2013
por: Head, Michael G., et al.
Publicado: (2015) -
Comparing research investment to United Kingdom institutions and published outputs for tuberculosis, HIV and malaria: a systematic analysis across 1997–2013
por: Head, Michael G., et al.
Publicado: (2015) -
Estimated generic prices of cancer medicines deemed cost-ineffective in England: a cost estimation analysis
por: Hill, Andrew, et al.
Publicado: (2017) -
Cell line access to revolutionize the biosimilars market
por: Gotham, Dzintars
Publicado: (2018) -
Target prices for mass production of tyrosine kinase inhibitors for global cancer treatment
por: Hill, Andrew, et al.
Publicado: (2016)